Search


Catalyst Pharma CEO Richard Daly gives an overview of the company's three commercial products, and discusses the 'buy to build' model
He highlights the market penetration of FIRDAPSE, the differentiation he believes AGAMREE represents in the DMD space, and FYCOMPA. Plus,...
Sep 8, 2025






.png)
